Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs PLETHICO PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA PLETHICO PHARMA ABBOTT INDIA/
PLETHICO PHARMA
 
P/E (TTM) x 53.1 -0.1 - View Chart
P/BV x 19.3 0.0 115,313.4% View Chart
Dividend Yield % 1.1 0.0 -  

Financials

 ABBOTT INDIA   PLETHICO PHARMA
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-23
PLETHICO PHARMA
Mar-14
ABBOTT INDIA/
PLETHICO PHARMA
5-Yr Chart
Click to enlarge
High Rs22,482254 8,851.1%   
Low Rs16,15631 51,699.2%   
Sales per share (Unadj.) Rs2,517.0604.6 416.3%  
Earnings per share (Unadj.) Rs446.832.5 1,375.2%  
Cash flow per share (Unadj.) Rs479.751.3 934.4%  
Dividends per share (Unadj.) Rs325.000-  
Avg Dividend yield %1.70-  
Book value per share (Unadj.) Rs1,480.5473.7 312.5%  
Shares outstanding (eoy) m21.2534.07 62.4%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x7.70.2 3,253.7%   
Avg P/E ratio x43.24.4 985.0%  
P/CF ratio (eoy) x40.32.8 1,449.7%  
Price / Book Value ratio x13.00.3 4,334.2%  
Dividend payout %72.70-   
Avg Mkt Cap Rs m410,5134,859 8,448.9%   
No. of employees `000NANA-   
Total wages/salary Rs m5,6361,547 364.3%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m53,48720,598 259.7%  
Other income Rs m1,543419 367.8%   
Total revenues Rs m55,03021,017 261.8%   
Gross profit Rs m12,0552,938 410.3%  
Depreciation Rs m700642 108.9%   
Interest Rs m1601,747 9.2%   
Profit before tax Rs m12,738968 1,315.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3,244-138 -2,344.2%   
Profit after tax Rs m9,4941,107 857.7%  
Gross profit margin %22.514.3 158.0%  
Effective tax rate %25.5-14.3 -178.2%   
Net profit margin %17.85.4 330.3%  
BALANCE SHEET DATA
Current assets Rs m30,25118,877 160.3%   
Current liabilities Rs m12,06011,896 101.4%   
Net working cap to sales %34.033.9 100.4%  
Current ratio x2.51.6 158.1%  
Inventory Days Days8778 111.2%  
Debtors Days Days2198 1.1%  
Net fixed assets Rs m15,13514,269 106.1%   
Share capital Rs m213341 62.4%   
"Free" reserves Rs m31,24815,798 197.8%   
Net worth Rs m31,46016,139 194.9%   
Long term debt Rs m04,706 0.0%   
Total assets Rs m45,38633,146 136.9%  
Interest coverage x80.71.6 5,189.1%   
Debt to equity ratio x00.3 0.0%  
Sales to assets ratio x1.20.6 189.6%   
Return on assets %21.38.6 247.1%  
Return on equity %30.26.9 440.0%  
Return on capital %41.013.0 314.8%  
Exports to sales %0.421.4 1.9%   
Imports to sales %10.815.2 70.8%   
Exports (fob) Rs m2214,402 5.0%   
Imports (cif) Rs m5,7653,136 183.8%   
Fx inflow Rs m3104,402 7.0%   
Fx outflow Rs m5,8183,184 182.7%   
Net fx Rs m-5,5081,219 -452.0%   
CASH FLOW
From Operations Rs m8,9342,437 366.5%  
From Investments Rs m-1,477-6,265 23.6%  
From Financial Activity Rs m-6,3872,490 -256.5%  
Net Cashflow Rs m1,07024 4,369.3%  

Share Holding

Indian Promoters % 0.0 57.8 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 8.9 19.4 46.0%  
FIIs % 0.2 2.7 6.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 42.3 59.2%  
Shareholders   72,252 16,430 439.8%  
Pledged promoter(s) holding % 0.0 85.7 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Abbott India vs PLETHICO PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Abbott India vs PLETHICO PHARMA Share Price Performance

Period Abbott India PLETHICO PHARMA S&P BSE HEALTHCARE
1-Day 0.67% -4.91% 0.88%
1-Month -3.13% -1.24% -4.09%
1-Year 34.31% -70.21% 59.00%
3-Year CAGR 25.47% -66.86% 18.97%
5-Year CAGR 31.27% -51.20% 19.20%

* Compound Annual Growth Rate

Here are more details on the Abbott India share price and the PLETHICO PHARMA share price.

Moving on to shareholding structures...

The promoters of Abbott India hold a 75.0% stake in the company. In case of PLETHICO PHARMA the stake stands at 57.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Abbott India and the shareholding pattern of PLETHICO PHARMA.

Finally, a word on dividends...

In the most recent financial year, Abbott India paid a dividend of Rs 325.0 per share. This amounted to a Dividend Payout ratio of 72.7%.

PLETHICO PHARMA paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of Abbott India, and the dividend history of PLETHICO PHARMA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Why Adani Group Stocks are Falling | Baazar Style Retail Files for IPO | Top Buzzing Stocks Today Why Adani Group Stocks are Falling | Baazar Style Retail Files for IPO | Top Buzzing Stocks Today(Pre-Open)

On Monday, Indian share markets reversed the trend as the session progressed and ended the day higher.